Exane Derivatives’s Raytheon Company RTN Stock Holding History
Bought
Maintained
Sold
Other funds holding RTN
PG
UIM
ELI
FPCG
MIS
VW
WBC
ALAM
WAS
DAM
Exane Derivatives's RTN Position: Q2 2020 in Review
Exane Derivatives sold out of Raytheon Company (RTN) in Q2 2020, closing a stake of 6 shares — an estimated $787 sold.
Exane Derivatives first reported a position in RTN in Q2 2015 and held it in 13 quarters. The position peaked at $21.6M in Q2 2015. 75 funds tracked by Wall St. Rank hold RTN as of Q2 2020.
- Exane Derivatives reported no remaining Raytheon Company position as of Q2 2020 after selling out during the quarter.
- Exane Derivatives sold 6 Raytheon Company shares in Q2 2020, an estimated $787.
- Exane Derivatives first reported a position in Raytheon Company in Q2 2015 and held it in 13 quarters.
- Exane Derivatives's Raytheon Company position peaked at $21.6M in Q2 2015.
- 75 funds tracked by Wall St. Rank held Raytheon Company as of Q2 2020.
Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.